Jose V. Castell

Valencia, VC 46010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Organobodies: a robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening.

Organobodies: a robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening.

Journal: Biofabrication

Published: December 05, 2025

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

Journal: Archives of toxicology

Published: June 20, 2025

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 09, 2025

Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy

Published: April 07, 2025

The acyl glucuronide of 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid: Synthesis, structural assignment, occurrence as a human phase II metabolite of Uvinul® A Plus and acute aquatic toxicity.

The acyl glucuronide of 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid: Synthesis, structural assignment, occurrence as a human phase II metabolite of Uvinul® A Plus and acute aquatic toxicity.

Journal: Chemosphere

Published: December 30, 2024

A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy.

A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy.

Journal: Toxicology

Published: September 10, 2024

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.

Journal: International journal of molecular sciences

Published: March 25, 2024

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.

Journal: International journal of molecular sciences

Published: February 05, 2024

Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders.

Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders.

Journal: Alternatives to laboratory animals : ATLA

Published: January 18, 2024

Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches.

Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches.

Journal: Toxicology

Published: December 22, 2023

Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data.

Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data.

Journal: Analytica chimica acta

Published: October 13, 2023

Protectiveness of NAM-based hazard assessment - which testing scope is required?

Protectiveness of NAM-based hazard assessment - which testing scope is required?

Journal: ALTEX

Published: September 08, 2023

Showing 1-12 of 98

Last Updated: 09/26/2026